Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Short-term Investments (2022 - 2025)

Historic Short-term Investments for Treace Medical Concepts (TMCI) over the last 4 years, with Q3 2025 value amounting to $49.7 million.

  • Treace Medical Concepts' Short-term Investments fell 2964.96% to $49.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $49.7 million, marking a year-over-year decrease of 2964.96%. This contributed to the annual value of $64.3 million for FY2024, which is 4163.55% down from last year.
  • Treace Medical Concepts' Short-term Investments amounted to $49.7 million in Q3 2025, which was down 2964.96% from $61.2 million recorded in Q2 2025.
  • Treace Medical Concepts' 5-year Short-term Investments high stood at $141.0 million for Q1 2023, and its period low was $49.7 million during Q3 2025.
  • For the 4-year period, Treace Medical Concepts' Short-term Investments averaged around $86.8 million, with its median value being $73.8 million (2024).
  • In the last 5 years, Treace Medical Concepts' Short-term Investments surged by 7840.37% in 2023 and then tumbled by 4163.55% in 2024.
  • Treace Medical Concepts' Short-term Investments (Quarter) stood at $61.8 million in 2022, then skyrocketed by 78.4% to $110.2 million in 2023, then crashed by 41.64% to $64.3 million in 2024, then dropped by 22.69% to $49.7 million in 2025.
  • Its last three reported values are $49.7 million in Q3 2025, $61.2 million for Q2 2025, and $62.7 million during Q1 2025.